Daniel Bitton heads Axinn’s West Coast antitrust practice. Trained in the EU and US, Daniel navigates Fortune 500 clients through antitrust litigation, government investigations and merger clearance processes across the globe. For a second consecutive year, Who's Who Legal named him one of the five "most highly regarded" Future Leaders in Competition in North America (2017 & 2018). He has also been named a Rising Star by both Super Lawyers and New York Law Journal. Chambers likewise has recognized Daniel as an Up-and-Coming Lawyer in antitrust.
Daniel has earned high praise from clients for his role in resolving high-stakes competition matters. His recent work includes the defence of a Danish conglomerate in international cartel litigation, securing global clearance for Johnson Controls’ $2 billion sale of Scott Safety to 3M, securing clearance for McKesson’s $3.4 billion joint venture with Change Healthcare and several other transactions, securing global clearance of Dell’s $67 billion acquisition of EMC, securing global clearance for Thermo Fisher’s $13.6 billion acquisition of Life Technologies, and representing Google in government investigations, litigation, and major transactions.